Search for: "TEVA PHARMACEUTICAL INDUSTRIES LTD" Results 41 - 60 of 260
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
12 Jan 2017, 11:11 am by Neil Wilkof
There is no pharmaceutical company that better reflects the challenges of trying to master both these product markets than the Israeli-based company, Teva Pharmaceutical Industries Ltd. [read post]
9 Jan 2017, 9:36 am by Lawrence B. Ebert
In other words, Copaxone should remain a $4 billion drug, annually.link to Pantagraph: http://www.pantagraph.com/business/investment/markets-and-stocks/factors-that-sent-teva-pharmaceutical-industries-ltd-sliding-in/article_74234eee-a5ec-5c58-a54b-82597151b1e6.htmlPatents covering "three per week" dosing were not at issue in the Supreme Court case of Teva Pharmaceuticals USA, Inc. v. [read post]
30 Dec 2016, 2:58 pm
Permission to appeal in patent cases - farewell to the Pozzoli approachGuest Kat Eibhlin Vardy recaps the case Teva UK Ltd v Boehringer Ingelheim Pharma GmbH & Co KG, [2016] EWCA Civ 1296. [read post]
The world’s largest manufacturer of generic pharmaceuticals, Israeli-based Teva Pharmaceutical Industries Ltd. [read post]
8 Nov 2016, 11:53 pm by Kevin LaCroix
  Next, on November 6, 2016, plaintiffs’ lawyers’ filed a securities class action lawsuit in the Central District of California against Teva Pharmaceuticals Industries Ltd. [read post]
2 Sep 2016, 1:57 pm by John Stigi
  There, plaintiffs brought a putative class action complaint challenging the sale of Auspex Pharmaceuticals, Inc. to Teva Pharmaceuticals Industries, Inc. [read post]
25 Aug 2016, 2:11 pm by Lawrence B. Ebert
Finance.yahoo noted a PTAB ruling on some of Teva's Copaxone patents:Teva Pharmaceutical Industries Ltd. today [August 24, 2016] confirmed the Patent Trial and Appeal Board (PTAB) decisions from an Inter Partes Review (IPR) to invalidate all claims of the ‘250 and ‘413 patents for 40 mg COPAXONE® (glatiramer acetate injection). [read post]
24 Apr 2016, 9:02 pm by Patent Docs
Biocon Ltd. et al. 1:16-cv-00278; filed April 19, 2015 in the District Court of Delaware • Plaintiffs: Teva Pharmaceuticals USA Inc.; Teva Pharmaceutical Industries Ltd.; Teva Neuroscience Inc; Yeda Research and Development Co Ltd. [read post]
17 Mar 2016, 12:12 pm
The allegations of infringement have been directed at Defendants Teva Pharmaceuticals USA, Inc. of North Wales, Pennsylvania and its parent company Teva Pharmaceutical Industries Ltd. of Israel. [read post]
17 Jan 2016, 8:19 pm by Patent Docs
• Defendants: Teva Pharmaceuticals USA Inc.; Teva Pharmaceutical Industries Ltd. [read post]
31 Dec 2015, 8:16 pm by Patent Docs
• Defendants: Teva Pharmaceuticals USA, Inc.; Teva Pharmaceutical Industries Ltd. [read post]
1 Dec 2015, 6:20 am
”) to ward off an unsolicited takeover bid by the Israeli pharmaceutical company Teva Pharmaceutical Industries Ltd. [read post]
7 Sep 2015, 1:02 pm
Pointing to a number of shortcomings in patents in agriculture and pharmaceuticals, The Economist concludes that patents don’t. [read post]
26 Aug 2015, 11:02 am by Lawrence B. Ebert
., Ltd. and licensed to Teva Pharmaceuticals Industries Ltd. [read post]
26 Jun 2015, 7:44 am
Law360.com provides insight into the background of the dispute in an article (subscription required for full access) that begins, "Drug purchasers challenging a no-authorized-generic settlement between GlaxoSmithKline PLC and Teva Pharmaceutical Industries ltd. told the Third Circuit on Friday that the U.S. [read post]